Leidos (LDOS) reported $4.25 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 6.8%. EPS of $2.97 for the same period compares to $2.29 a year ago.The reported revenue represents a surprise of +4.03% over the Zacks Consensus Estimate of $4.08 billion. With the consensus EPS estimate being $2.47, the EPS surprise was +20.24%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expec ...

Leidos (LDOS) came out with quarterly earnings of $2.97 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 20.24%. A quarter ago, it was expected that this security and engineering company would post earnings of $2.18 per share when it actually produced earnings of $2.37, delivering a surprise of 8.72%.Over the last four quarter ...

Leidos (LDOS) Q1 2025 Earnings Call May 06, 2025 08:00 AM ET Speaker0 Greetings. Welcome to Leidos First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. Please note this conference is being recorded. At this time, I'll turn the conference over to Stuart Davis from Investor Relations. Stuart, you may begin. Speaker1 Thank you, and good morning, everyone. I'd like to welcome ...

Leidos (LDOS) Q1 2025 Earnings Call May 06, 2025 08:00 AM ET Company Participants Stuart Davis - Senior Vice President, Investor RelationsThomas Bell - CEOChris Cage - Executive VP & CFOJoshua Korn - Assistant VP, Equity ResearchSheila Kahyaoglu - Aerospace & Defense and Airlines Equity ResearchColin Canfield - DirectorMariana Pérez Mora - DirectorJason Gursky - Managing DirectorTyler Barishaw - Equity Research AssociateScott Mikus - Director – Aerospace, Defense & Space ResearchKen Herbert - Managing Direc ...

Leidos Q1 FY25 Earnings Conference Call MAY 6, 2025 FORWARD-LOOKING STATEMENTS Certain statements in this release contain or are based on "forward- looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance" and similar words or phrases. Forward-looking statements in this release include, among others, estimates of ...

SUMMARY OPERATING RESULTS | | | | Three Months Ended | | | --- | --- | --- | --- | --- | | (in millions, except margin and per share data) | | April 4, 2025 | | March 29, 2024 | | Revenues | $ | 4,245 | $ | 3,975 | | Net income | $ | 365 | $ | 283 | | Net income margin | | 8.6 % | | 7.1 % | | Diluted earnings per share (EPS) | $ | 2.77 | $ | 2.07 | | Non-GAAP Measures*: | | | | | | Adjusted EBITDA | $ | 601 | $ | 490 | | Adjusted EBITDA margin | | 14.2 % | | 12.3 % | | Non-GAAP diluted EPS | $ | 2.97 | $ | ...

RESTON, Va., May 5, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) will modernize and operate information technology systems for the Defense Threat Reduction Agency (DTRA) enterprise that will help the agency deter, prevent and prevail against emerging threats around the world.  As part of this IT transformation, Leidos will support DTRA's advance toward a Zero Trust cybersecurity posture.Through a recently awarded $205 million contract, Leidos will use artificial intelligence technologies to accelerate DTRA's pro ...

RESTON, Va., April 18, 2025 /PRNewswire/ -- Leidos (NYSE: LDOS) is committing $10 million to accelerate the use of artificial intelligence for detecting and managing diseases, in collaboration with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE).The initial focus of the five-year collaboration will be developing AI-powered tools for quicker detection of diseases, such as heart disease and cancer, reducing diagnostic turnaround times, and enabling earlier, more effe ...

Core Insights - Leidos Holdings, Inc. operates in the defense, IT security, data analytics, and healthcare sectors, having undergone a realignment to report four segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems [1] Company Overview - Leidos has a significant presence in multiple industries, focusing on defense and technology solutions [1] - The company is publicly traded on the NYSE under the ticker symbol LDOS [1]

Core Viewpoint - Leidos (LDOS) is positioned well to potentially beat earnings estimates in its upcoming quarterly report, supported by a strong history of exceeding expectations in previous quarters [1]. Group 1: Earnings Performance - Leidos has a solid track record of surpassing earnings estimates, with an average surprise of 29.10% over the last two quarters [2]. - In the last reported quarter, Leidos achieved earnings of $2.37 per share, exceeding the Zacks Consensus Estimate of $2.18 per share by 8.72% [3]. - In the previous quarter, the company reported earnings of $2.93 per share against an expectation of $1.96 per share, resulting in a surprise of 49.49% [3]. Group 2: Earnings Estimates and Predictions - Recent favorable changes in earnings estimates for Leidos indicate a positive Earnings ESP (Expected Surprise Prediction), which is a strong indicator of a potential earnings beat [6]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests that stocks like Leidos have a nearly 70% chance of producing a positive surprise [7]. - Leidos currently has an Earnings ESP of +1.15%, reflecting a bullish sentiment among analysts regarding the company's earnings prospects [9].